Mylan launches fluvastatin capsules

4/13/2012

PITTSBURGH — The Food and Drug Administration has approved a generic drug for lipid disorders made by Mylan, the company said Friday.



Mylan announced the approval and launch of fluvastatin capsules in the 20-mg and 40-mg strengths, a generic version of Novartis' Lescol. The drug is used to treat hypercholesterolemia and mixed dyslipidemia, as well as prevention of cardiovascular disease.



The drug had sales of $27.9 million in 2011, according to IMS Health.




Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

X
This ad will auto-close in 10 seconds